Anderson, M. A., Deng, J., Seymour, J. F., Tam, C., Kim, S. Y., Fein, J., . . . Roberts, A. W. (2016). The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. Blood.
Citação norma ChicagoAnderson, Mary Ann, et al. "The BCL2 Selective Inhibitor Venetoclax Induces Rapid Onset Apoptosis of CLL Cells in Patients Via a TP53-independent Mechanism." Blood 2016.
MLA citiranjeAnderson, Mary Ann, et al. "The BCL2 Selective Inhibitor Venetoclax Induces Rapid Onset Apoptosis of CLL Cells in Patients Via a TP53-independent Mechanism." Blood 2016.
Opozorilo: Ti citati niso vedno 100% točni.